DHT
Dược phẩm Hà Tây ·HNX ·2026Q1
▼ Under pressure
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, DHT is holding revenue at an acceptable level, but margins are eroding visibly — margins have been compressing consistently over multiple periods. What is still missing is better cost control to prevent margin pressure from spreading to the overall profit result.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 568.8 | 692.9 | 638.8 | 574.4 | 496.0 | 542.4 | 544.5 | 493.8 | 505.7 | 474.2 | 478.8 | 547.1 |
| Growth | -18% | +8% | +11% | +16% | -9% | -0% | +10% | -2% | +7% | -1% | -12% | — |
| Net Income | 9.0 | 10.2 | 11.5 | 13.4 | 23.9 | 20.4 | 20.3 | 18.4 | 16.2 | 16.8 | 18.7 | 26.0 |
| Net Margin | 1.58% | 1.47% | 1.80% | 2.33% | 4.82% | 3.75% | 3.72% | 3.73% | 3.19% | 3.55% | 3.91% | 4.74% |
Drivers of DHT's profit
Net profit attributable to parent declined vs last year, mainly due to lower gross profit. Supporting and offsetting drivers:
Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE fell from 7.8% to 4.0% — leverage weakened the most, though asset turnover still provided support.
Is the profit sustainable?
Margins are under pressure while earnings still rely significantly on non-core sources.
What is driving the margin?
Net margin fell to 1.78%, losing 2.2pp. The main pressure is Gross margin fell 3.2pp, outweighing the improvement in SG&A / Revenue fell 0.5pp (with additional support from Net financial result / Revenue rose 0.1pp and Other profit / Revenue rose 0.0pp).
The pressure comes from core operations — this is a concerning type of decline, not a one-off movement.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Watchpoints
Margin support from other income remains high (42.5% of PBT) — sustainability should be monitored.
Is capital being used efficiently?
Capital efficiency is declining — check whether the drag is from margins or turnover.
Is capital being deployed efficiently?
ROIC fell to 2.28%, losing 2.9pp. That translates to 2.28 in after-tax operating profit for every 100 units of operating capital. The main pressure came from NOPAT margin narrowed 2.3pp, outweighing the movement in capital turnover; with invested capital holding roughly steady.
Pressure came from the margin side — core operations are weakening, not just a temporary asset-management issue.
Watchpoints
ROIC is currently 2.28% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC declined — the balance sheet shows how capital is being deployed. Capital structure is conservative with low leverage — liabilities at 0.74x equity, net debt at 0.15x equity.
Inventory ended the period at 513.4bn, roughly 26.6% of total assets.
Over the last 12 months, working capital released 109.3bn of cash, mainly thanks to lower inventories. Pressure from higher receivables and lower payables only partly offset that benefit.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 14.3 days versus the same period last year. The main moves came from DIO fell 21.2 days, DSO fell 1.9 days, and DPO fell 8.8 days.
Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — leverage is safe, both CFO and FCF are positive.
Leverage & Liquidity
Leverage is balanced for now, with net debt / equity at 0.15x and interest coverage at 2.07x.
At present, short-term debt accounts for 73.0% of total debt, cash equals 45.0% of debt, and total debt stands at 307.6bn.
Watchpoints
Short-term debt accounts for 73.0% of total debt, raising near-term refinancing needs.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 225.7bn in 2025, against investing cash flow of -94.5bn.
Post-investment cash flow was positive +131.2bn. Financing cash flow was negative +137.1bn.
CFO / net income was 3.90x.
After spending +37.6bn on fixed-asset investment, the business generated trailing free cash flow of +123.8bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is cash generation. The next item to monitor is the earnings mix, when non-core contribution is 14.5%. The main risk still sits in core profitability, with net margin down 2.2 pp.
Improvement: cash generation is recovering, with trailing-12M FCF improving by 185.6bn versus the same period last year.
Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 3.90x. Even so, net financial result still accounts for 14.5% of PBT, so the earnings mix still needs monitoring.
Key risk: profitability remains under pressure, with trailing-12M net margin at 1.78% after a 2.2pp decline versus the same period last year.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
2,402.0 | 2,086.4 | 1,999.3 | 1,837.4 | 1,609.4 |
|
Cost of Goods Sold
|
2,192.9 | 1,866.5 | 1,796.0 | 1,650.1 | 0.0 |
|
Gross Profit
|
209.2 | 219.8 | 203.3 | 187.3 | 154.0 |
|
Financial Expenses
|
19.8 | 20.1 | 23.7 | 16.4 | -14.1 |
|
Selling Expenses
|
36.6 | 30.1 | 27.2 | 23.6 | -25.9 |
|
General and Administrative Expenses
|
131.9 | 113.2 | 76.9 | 61.2 | -66.1 |
|
Operating Profit
|
58.5 | 82.7 | 99.3 | 114.1 | 80.7 |
|
Profit Before Tax
|
73.3 | 95.2 | 110.3 | 123.2 | 89.5 |
|
Net Income
|
59.0 | 75.2 | 89.0 | 99.0 | 71.4 |
|
Profit Attributable to Parent
|
53.7 | 71.8 | 85.1 | 95.2 | 67.9 |
|
Earnings per Share
|
645.00 | 872.00 | 1,682.00 | 3,604.00 | 2,572.83 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.